全文获取类型
收费全文 | 656篇 |
免费 | 22篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 56篇 |
妇产科学 | 13篇 |
基础医学 | 100篇 |
口腔科学 | 21篇 |
临床医学 | 43篇 |
内科学 | 91篇 |
皮肤病学 | 1篇 |
神经病学 | 24篇 |
特种医学 | 13篇 |
外科学 | 84篇 |
综合类 | 10篇 |
一般理论 | 1篇 |
预防医学 | 55篇 |
眼科学 | 54篇 |
药学 | 61篇 |
中国医学 | 4篇 |
肿瘤学 | 44篇 |
出版年
2023年 | 3篇 |
2022年 | 23篇 |
2021年 | 21篇 |
2020年 | 13篇 |
2019年 | 8篇 |
2018年 | 24篇 |
2017年 | 15篇 |
2016年 | 17篇 |
2015年 | 26篇 |
2014年 | 41篇 |
2013年 | 43篇 |
2012年 | 62篇 |
2011年 | 69篇 |
2010年 | 29篇 |
2009年 | 37篇 |
2008年 | 40篇 |
2007年 | 57篇 |
2006年 | 24篇 |
2005年 | 29篇 |
2004年 | 17篇 |
2003年 | 14篇 |
2002年 | 17篇 |
2000年 | 7篇 |
1999年 | 5篇 |
1998年 | 5篇 |
1997年 | 3篇 |
1996年 | 2篇 |
1995年 | 4篇 |
1994年 | 1篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1988年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1982年 | 4篇 |
1981年 | 2篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1975年 | 2篇 |
1970年 | 1篇 |
1969年 | 1篇 |
1968年 | 1篇 |
1962年 | 1篇 |
排序方式: 共有679条查询结果,搜索用时 0 毫秒
31.
32.
33.
34.
35.
36.
Clinical Trial with Praneem Polyherbal Cream in Patients with Abnormal Vaginal Discharge Due to Microbial Infections 总被引:1,自引:0,他引:1
37.
Gangatirkar P Gangadharan S Narendranath A Nagpal S Salunke DM Karande AA 《Hybridoma and hybridomics》2002,21(4):281-286
Monoclonal antibodies (MAbs) specific to gonadotropin-releasing hormone (GnRH) were obtained using different strategies of conjugation of the peptide to carrier protein and immunization. Of several antibodies obtained, two, namely F1D3C5 and E2D2 bound GnRH in solution phase. Though the epitopes corresponding to the two overlapped, there was a one amino acid shift in the core epitope. These two antibodies were characterized with respect to inhibition of GnRH induced responses in rat pituitary cultures and alpha-T3.1 mouse gonadotrope cell line. 相似文献
38.
Undraa Altangerel Sushma Rai Joann Fontanarosa Marlene R Moster 《Ophthalmic surgery, lasers & imaging》2006,37(2):106-111
BACKGROUND AND OBJECTIVE: To evaluate the intracameral use of Healon5 (2.3% sodium hyaluronate) (Advanced Medical Optics, Santa Ana, CA) in patients with hypotony. PATIENTS AND METHODS: Fifteen consecutive patients with glaucoma who had hypotony for at least 7 days were prospectively recruited. Indications for the intracameral injection of Healon5 were an intraocular pressure (IOP) of less than 6 mm Hg with negative results on Seidel test. RESULTS: The mean IOP readings at baseline, 1 to 2 weeks post-injection, and 4 to 6 weeks post-injection were 3.8 +/- 1.58, 6.58 +/- 2.62, and 6.50 +/- 2.24 mm Hg, respectively. The increase in IOP at both follow-up points was significant (P < .01). The visual acuity improvement was small but significant at the 4 to 6 week point (P = .05). In the early-onset cases, IOP increased significantly from baseline at both follow-up points (P< .05), but visual acuity did not. No significant change from baseline IOP or visual acuity occurred among the late-onset cases. The existing hypotony-related conditions consistently improved by the 4 to 6 week point. CONCLUSIONS: Intracameral injection of Healon5 raised IOP more in early-onset hypotony cases than in late-onset cases. Although the improvements in IOP and visual acuity were statistically significant, the overall clinical picture did not change because the endpoint IOP was still hypotonus. Twenty percent of the patients had IOP spikes that required medical treatment. 相似文献
39.
40.
Significant advances in the understanding of the genetic abnormalities that lead to the development, progression, and metastasis of neoplastic diseases has raised the promise of gene therapy as an approach to medical intervention. Most of the clinical protocols that have been approved in the United States for gene therapy have used the viral vectors because of the high efficiency of gene transfer. Conventional means of gene delivery using viral vectors, however, has undesirable side effects such as insertion of mutational viral gene into the host genome and development of replication competent viruses. Among non-viral gene delivery methods, polymeric nanoparticles are increasingly becoming popular as vectors of choice. The major limitation of these nanoparticles is poor transfection efficiency at the target site after systemic administration due to uptake by the cells of reticuloendothelial system (RES). In order to reduce the uptake by the cells of the RES and improve blood circulation time, these nanoparticles are coated with hydrophilic polymers such as poly(ethylene glycol) (PEG). This article reviews the use of such hydrophilic polymers employed for improving the circulation time of the nanocarriers. The mechanism of polymer coating and factors affecting the circulation time of these nanocarriers will be discussed. In addition to the long circulating property, modifications to improve the target specificity of the particles and the limitations of steric protection will be analyzed. 相似文献